The effects of PAHs and N-PAHs on retinoid signaling and Oct-4 expression in vitro

Toxicology Letters

Volumn 200, Issue 3, 2011, Pages 169-175

  Beníšek, Martin ^a   Kubincová, Petra ^a   Bláha, Luděk ^a   Hilscherová, Klára ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Differentiation; N PAHs; Oct 4; PAHs; Retinoids

Indexed keywords

1,7 PHENANTHROLINE; BENZ[A]ANTHRACENE; BENZ[C]ACRIDINE; OCTAMER TRANSCRIPTION FACTOR 4; PHENANTHRENE; POLYCYCLIC AROMATIC HYDROCARBON; RETINOIC ACID; RETINOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; EMBRYOTOXICITY; IN VITRO STUDY; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; DOWN-REGULATION; ENVIRONMENTAL POLLUTANTS; GENE EXPRESSION; GENES, REPORTER; HETEROCYCLIC COMPOUNDS; LUCIFERASES; MICE; OCTAMER TRANSCRIPTION FACTOR-3; POLYCYCLIC HYDROCARBONS, AROMATIC; RETINOIDS; TRETINOIN; UP-REGULATION; XENOBIOTICS;

EID: 78651076114     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.11.011     Document Type: Article

References (47)

1. Abbott B.D., Birnbaum L.S. Cellular alterations and enhanced induction of cleft-palate after coadministration of retinoic acid and TCDD. Toxicology and Applied Pharmacology 1989, 99:287-301.
2. Barnea E., Bergman Y. Synergy of SF1 and RAR in activation of Oct-3/4 promoter. Journal of Biological Chemistry 2000, 275:6608-6619.
3. Bastien J., Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 2004, 328:1-16.
4. Benisek M., Blaha L., Hilscherova K. Interference of PAHs and their N-heterocyclic analogs with signaling of retinoids in vitro. Toxicology in Vitro 2008, 22:1909-1917.
5. Benshushan E., Sharir H., Pikarsky E., Bergman Y. A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor retinoid-X-receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma-cells. Molecular and Cellular Biology 1995, 15:1034-1048.
6. Billiard S.M., Meyer J.N., Wassenberg D.M., Hodson P.V., Di Giulio R.T. Nonadditive effects of PAHs on early vertebrate development: mechanisms and implications for risk assessment. Toxicological Sciences 2008, 105:5-23.
7. Blomhoff R., Blomhoff H.K. Overview of retinoid metabolism and function. Journal of Neurobiology 2006, 66:606-630.
8. Breems-de Ridder M.C., Lowenberg B., Jansen J.H. Retinoic acid receptor fusion proteins: friend or foe. Molecular and Cellular Endocrinology 2000, 165:1-6.
9. Brehm A., Ovitt C.E., Scholer H.R. Oct-4: more than just a POUerful marker of the mammalian germline?. Apmis 1998, 106:114-124.
10. Buryskova B., Hilscherova K., Blaha L., Marsalek B., Holoubek I. Toxicity and modulations of biomarkers in Xenopus laevis embryos exposed to polycyclic aromatic hydrocarbons and their N-heterocyclic derivatives. Environmental Toxicology 2006, 21:590-598.
11. Chen G.Q., Lin B.Z., Dawson M.I., Zhang X.K. Nicotine modulates the effects of retinoids on growth inhibition and RAR beta expression in lung cancer cells. International Journal of Cancer 2002, 99:171-178.
12. Eifert C., Sangster-Guity N., Yu L.M., Chittur S.V., Perez A.V., Tine J.A., McCormick P.J. Global gene expression profiles associated with retinoic acid-induced differentiation of embryonal carcinoma cells. Molecular Reproduction and Development 2006, 73:796-824.
13. Faherty S., Kane M.T., Quinlan L.R. Self-renewal and differentiation of mouse embryonic stem cells as measured by Oct4 gene expression: effects of LIF, serum-free medium, retinoic acid, and dbcAMP. In Vitro Cellular & Developmental Biology-Animal 2005, 41:356-363.
14. Fallone F., Villard P.H., Seree E., Rimet O., Nguyen Q.B., Bourgarel-Rey W., Fouchier F., Barra Y., Durand A., Lacarelle B. Retinoids repress Ah receptor CYP1A1 induction pathway through the SMRT corepressor. Biochemical and Biophysical Research Communications 2004, 322:551-556.
15. Feng Y.C., Shi G.L., Wu J.H., Wang Y.Q., Zhu T., Dai S.G., Pei Y.Q. Source analysis of particulate-phase polycyclic aromatic hydrocarbons in an urban atmosphere of a northern city in China. Journal of the Air & Waste Management Association 2007, 57:164-171.
16. Fields A.L., Soprano D.R., Soprano K.J. Retinoids in biological control and cancer. Journal of Cellular Biochemistry 2007, 102:886-898.
17. Freyberger A., Schmuck G. Screening for estrogenicity and anti-estrogenicity: a critical evaluation of an MVLN cell-based transactivation assay. Toxicology Letters 2005, 155:1-13.
18. Gupta P., Ho P.C., Huq M., Ha S.G., Park S.W., Khan A.A., Tsai N.P., Wei L.N. Retinoic acid-stimulated sequential phosphorylation, PML recruitment, and SUMOylation of nuclear receptor TR2 to suppress Oct4 expression. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:11424-11429.
19. Hough S.R., Clements I., Welch P.J., Wiederholt K.A. Differentiation of mouse embryonic stem cells after RNA interference-mediated silencing of OCT4 and Nanog. Stem Cells 2006, 24:1467-1475.
20. Jung D.K.J., Klaus T., Fent K. Cytochrome P450 induction by nitrated polycyclic aromatic hydrocarbons, azaarenes, and binary mixtures in fish hepatoma cell line PLHC-1. Environmental Toxicology and Chemistry 2001, 20:149-159.
21. Kaji K., Norrby K., Paca A., Mileikovsky M., Mohseni P., Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009.
22. Kusakawa S., Yamauchi J., Miyamoto Y., Sanbe A., Tanoue A. Estimation of embryotoxic effect of fluoxetine using embryonic stem cell differentiation system. Life Sciences 2008, 83:871-877.
23. Li J., Ma M., Wang Z.J. A two-hybrid yeast assay to quantify the effects of xenobiotics on retinoid X receptor-mediated gene expression. Toxicology Letters 2008, 176:198-206.
24. Lindenau A., Fischer B. Embryotoxicity of polychlorinated biphenyls (PCBs) for preimplantation embryos. Reproductive Toxicology 1996, 10:227-230.
25. Love J.M., Gudas L.J. Vitamin-A, differentiation and cancer. Current Opinion in Cell Biology 1994, 6:825-831.
26. Maden M. The role of retinoic acid in embryonic: and post-embryonic development. Summer Meeting of the Nutrition-Society 1999, 65-73.
27. McBurney M.W., Jonesvilleneuve E.M.V., Edwards M.K.S., Anderson P.J. Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell-line. Nature 1982, 299:165-167.
28. McSorley L.C., Daly A.K. Identification of human cytochrome P450 isoforms that contribute to all-trans-Retinoic Acid 4-hydroxylation. Biochemical Pharmacology 2000, 60:517-526.
29. Minucci S., Leid M., Toyama R., SaintJeannet J.P., Peterson V.J., Horn V., Ishmael J.E., Bhattacharyya N., Dey A., Dawid I.B., Ozato K. Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression. Molecular and Cellular Biology 1997, 17:644-655.
30. Niwa H., Miyazaki J., Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nature Genetics 2000, 24:372-376.
31. Novak J., Benisek M., Hilscherova K. Disruption of retinoid transport, metabolism and signaling by environmental pollutants. Environment International 2008, 34:898-913.
32. Novak J., Benisek M., Pachernik J., Janosek J., Sidlova T., Kiviranta H., Verta M., Giesy J.P., Blaha L., Hilscherova K. Interference of contaminated sediment extracts and environmental pollutants with retinoid signaling. Environmental Toxicology and Chemistry 2007, 26:1591-1599.
33. Pachernik J., Bryja V., Esner M., Kubala L., Dvorak P., Hampl A. Neural differentiation of pluripotent mouse embryonal carcinoma cells by retinoic acid: inhibitory effect of serum. Physiological Research 2005, 54:115-122.
34. Pesce M., Scholer H.R. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 2001, 19:271-278.
35. Pikarsky E., Sharir H., Benshushan E., Bergman Y. Retinoic acid represses Oct-3/4 gene-expression through several retinoic acid-responsive elements located in the promoter-enhancer region. Molecular and Cellular Biology 1994, 14:1026-1038.
36. Rummel A.M., Trosko J.E., Wilson M.R., Upham B.L. Polycyclic aromatic hydrocarbons with bay-like regions inhibited gap junctional intercellular communication and stimulated MAPK activity. Toxicological Sciences 1999, 49:232-240.
37. Santodonato J. Review of the estrogenic and antiestrogenic activity of polycyclic aromatic hydrocarbons: relationship to carcinogenicity. Chemosphere 1997, 34:835-848.
38. Schoorlemmer J., Jonk L., Shen S.B., vanPuijenbroek A., Feijen A., Kruijer W. Regulation of Oct-4 gene expression during differentiation of EC cells. Molecular Biology Reports 1995, 21:129-140.
39. Sovadinova I., Blaha L., Janosek J., Hilscherova K., Giesy J.P., Jones P.D., Holoubek I. Cytotoxicity and aryl hydrocarbon receptor-mediated activity of N-heterocyclic polycyclic aromatic hydrocarbons: Structure-activity relationships. Environmental Toxicology and Chemistry 2006, 25:1291-1297.
40. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
41. Thier M., Roeb E., Breuer B., Bayer T.A., Halfter H., Weis J. Expression of matrix metalloproteinase-2 in glial and neuronal tumor cell lines: inverse correlation with proliferation rate. Cancer Letters 2000, 149:163-170.
42. Tzimas G., Nau H. The role of metabolism and toxicokinetics in retinoid teratogenesis. Current Pharmaceutical Design 2001, 7:803-831.
43. Upham B.L., Blaha L., Babica P., Park J.S., Sovadinova I., Pudrith C., Rummel A.M., Weis L.M., Sai K., Tithof P.K., Guzvic M., Vondracek J., Machala M., Trosko J.E. Tumor promoting properties of a cigarette smoke prevalent polycyclic aromatic hydrocarbon as indicated by the inhibition of gap junctional intercellular communication via phosphatidylcholine-specific phospholipase C. Cancer Science 2008, 99:696-705.
44. Widerak M., Ghoneim C., Dumontier M.F., Quesne M., Corvol M.T., Savouret J.F. The aryl hydrocarbon receptor activates the retinoic acid receptor alpha through SMRT antagonism. Biochimie 2006, 88:387-397.
45. Wilson V.S., Bobseine K., Lambright C.R., Gray L.E. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. Toxicological Sciences 2002, 66:69-81.
46. Zdravkovic T., Genbacev O., LaRocque N., McMaster M., Fisher S. Human embryonic stem cells as a model system for studying the effects of smoke exposure on the embryo. Reproductive Toxicology 2008, 26:86-93.
47. Zhang H.P., Guo D.X., Wang L.Y., Zhao Y.X., Cheng Y., Qiao Z.D. Effect of nicotine on Oct-4 and Rex-1 expression of mouse embryonic stem cells. Reproductive Toxicology 2005, 19:473-478.